Aim: To appraise existing alcohol guidelines for identifying and managing harmful alcohol use in primary healthcare settings. Methods: Seven databases and 18 health organization or medical society websites were systematically searched from inception to 31 October 2016. Guidelines in English language, developed by a national or international medical specialty society, government or health organization, and containing recommendations for identifying and managing harmful use of alcohol in primary healthcare settings, were included. The Appraisal of Guidelines Research and Evaluation II (AGREE II) instrument was used to appraise the guidelines. Results: Of the 970 literature identified, 17 were included for review, with 13 guidelines developed for use in Western countries and 4 for international use. The AGREE II scores ranged from 2.0 to 5.3, out of 7. Variations in terminology of harmful alcohol use were seen, with 'harmful drinking' and 'problem drinking' being mostly used. All guidelines were in favor of screening and brief interventions due to their effectiveness and cost-effectiveness. Potential benefits and costs of applying screening and brief interventions were found, but there was a lack of evidence for longterm effects or specific populations. Conclusions: All 17 guidelines recommended screening and brief interventions due to its associated health and financial benefits. Policy makers are highly encouraged to integrate these practices into primary healthcare settings taking the drinking status, culture and resources into account. Short summary: Screening and brief interventions were recommended by all 17 guidelines on managing patients with harmful use of alcohol in primary healthcare settings. Policy makers and healthcare practitioners are highly encouraged to implement these recommendations.
INTRODUCTION
The harmful use of alcohol is defined as a pattern of alcohol use that is causing damage to one's physical and/or mental health according to the 10th Revision of the International Statistical Classification of Diseases and Related Health Problems (ICD-10) (The code in the ICD-10 is F10.1) (World Health Organization (WHO), 1993) . It is coded equally to 'alcohol abuse' (code: 305.00) in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) (American Psychiatric Association, 2000) , or 'mild alcohol use disorder' (code: 305.00) in the DSM-5 since 2013 (American Psychiatric Association, 2013) .
Though people with harmful use of alcohol do not have alcohol dependence (the most serious form of drinking problem as a result of an individual's persistent use of alcohol due to a strong and uncontrollable desire to drink despite significant alcohol-related problems in tolerance, withdrawal and social impairment), their use of alcohol already causes damage to health and induces adverse social consequences. The prevalence of harmful use of alcohol is much higher than alcohol dependence, e.g. it appeared in 24% of the adult population while alcohol dependence was found in 4% of the adult population in England (Drummond et al., 2005; McManus et al., 2009) . In 2012, 3.3 million deaths worldwide were attributable to harmful drinking, representing 5.9% of all deaths (WHO, 2014a) . Globally, alcohol use, together with childhood underweight and unsafe sex, is one of the three leading health risks causing significant disability-adjusted life years (DALYs) (WHO, 2009 ). In particular, harmful drinking is the leading risk factor for death in men aged 15-59 years, and is known to increase the risk of more than 200 diseases, e.g. liver disease, various cancers and infectious diseases such as tuberculosis and HIV/AIDS (WHO, 2014a) . Harmful use of alcohol may lead to unintentional and intentional injuries due to road traffic accidents, violence, suicide, child neglect and abuse, besides absenteeism from the workplace (WHO, 2014a (WHO, , 2015 . In summary, harmful use of alcohol causes significant negative effects and burdens not only to individuals but also to the society as a whole.
Priority should be given by policy makers to reduce harmful alcohol use due to its scope and nature of the disease burdens and related harms. The WHO has published an international policy framework to help countries develop health policies in several areas, including policies for health services, where early identification and management of people with harmful use of alcohol were suggested (WHO, 2010c) . Unlike people with alcohol dependence who needs intensive care provided by psychiatric specialists (O'Flynn, 2011) , those with harmful use of alcohol are found to respond well to brief counseling provided by non-specialists such as general practitioners, nurses and allied healthcare professionals in primary care (Kaner et al., 2007; O'Donnell et al., 2014) . And primary healthcare settings are regarded as important settings for tackling and preventing alcohol-related problems, by providing the first-contact, continuous, coordinative, community-based and patient-centred holistic care. However, the consequences of harmful use of alcohol are not fully recognized, and attentions are needed to focus on this group of people who may frequently visit primary care professionals because of their physical or mental problems. Recommendations and evidence are needed to endorse policy makers and healthcare professionals in managing harmful drinking in primary healthcare (Lock, 2004) .
Several countries and organizations have developed guidelines for use with regards to a broad spectrum of alcohol users. However, there is a lack of summary and appraisal of these guidelines. Efforts are greatly desired to appraise the quality of different guidelines, summarize the recommendations and urge their implementations in managing people with harmful use of alcohol in primary care, especially in many countries or areas where such services and policy have not been established yet. Therefore, the aim of this study was to systematically appraise the available guidelines and summarize the recommendations related to managing harmful use of alcohol in primary healthcare. These findings may assist policy makers in developing their own relevant guidelines or in modifying existing alcohol guidelines. Individual primary healthcare providers may also use these findings to provide better quality care for patients with harmful use of alcohol.
MATERIALS AND METHODS
Details of the methods can be seen in Supplementary Material. Quality assessment of the guidelines using the validated Appraisal of Guidelines Research and Evaluation II (AGREE II) instrument can be seen in Supplementary Table S1 .
RESULTS
Of the 970 results obtained, 93 were excluded due to duplication, 816 were excluded due to not part of guideline, not for primary care, not related to alcohol or focused on harmful drinking, not about counseling, and/or adapted from existing guideline or not being used anymore, 61 were included for review of full text, and 17 were included for final full data extraction ( Fig. 1) (WHO, 2001b (WHO, , 2010b (WHO, , 2010d (WHO, , 2014c Five guidelines were developed in the USA, by the VA/DOD (2015), the NIAAA (2002 NIAAA ( , 2005 , the US Preventive Services Task Force (USPSTF) (Moyer, 2013) and CDC (2014); two were developed in Australia, by the DHA (2009) and the NCETA Consortium (2004); two in Canada, by the SOGC (2010) and RNAO (2015) ; two in the UK, by the NICE one in Scotland, by the SIGN (2003) ; one in Europe, by the DHGC (2005) and four were developed by the WHO (2001b WHO ( , 2010b WHO ( , 2010d WHO ( , 2014c (Table 1) . Four (WHO, 2001b (WHO, , 2010b DHA, 2009; NICE, 2010) guidelines were accompanied by supporting documents or evidence reports (WHO, 2001a (WHO, , 2010a Proude et al., 2009; Jackson et al., 2010; Latimer et al., 2010) . Table 2 illustrates the AGREE II scores of the 17 guidelines. The mean overall AGREE II scores of the three appraisers ranged from 2.0 to 5.3 out of 7, with the NIAAA guideline (2005) scoring the lowest, and the Australian guideline (DHA, 2009) and the Canadian guideline (SOGC, 2010) scoring the highest. Of this, 8 out of 17 guidelines had a rigor of development score more than 50% of the possible score of 63 for this domain (SIGN, 2003; DHA, 2009; SOGC, 2010; NICE, 2010 NICE, , 2011 WHO, 2014c; RNAO, 2015; VA/ DOD, 2015) . Only 4 out of 17 guidelines had an applicability score of more than 50% of the maximum possible score (score of 84) (DHGC, 2005; NICE, 2010; WHO, 2014c; RNAO, 2015) . Furthermore, 15 guidelines scored more than 50% of the maximum possible score in domain of clarity of presentation (score of 63) (WHO, 2001b (WHO, , 2010b (WHO, , 2010d (WHO, , 2014c NIAAA, 2002; SIGN, 2003; DHGC, 2005; DHA, 2009; SOGC, 2010; NICE, 2010 NICE, , 2011 Moyer, 2013; CDC, 2014; RNAO, 2015; VA/DOD, 2015) .
Appraisal results

Variations in terminology
Variations in terminology of 'harmful alcohol use' were found. Eight guidelines adopted the term 'harmful drinking' (WHO, 2001b (WHO, , 2010d (WHO, , 2014c SIGN, 2003; NCETA Consortium, 2004; DHGC, 2005; NICE, 2010 NICE, , 2011 , using the ICD-10 definition (WHO, 1993) . Other terminology used were 'problem drinking' (or equivalent) (NIAAA, 2002; DHA, 2009; SOGC, 2010; VA/DOD, 2015) , 'moderate risk of substance use ' (WHO, 2010b) , 'alcohol misuse' (Moyer, 2013) or 'risky drinking' (CDC, 2014; RNAO, 2015) as well as 'alcohol abuse ' (NIAAA, 2005) , following the DSM-IV criteria (American Psychiatric Association, 2000) , which is the equivalent to the WHO's terms of hazardous and harmful drinking with regard to the health consequences (WHO, 2014b) . From the definition by the WHO (2001b), hazardous drinking is a pattern of alcohol consumption carrying risk of harmful consequences to the drinker, including damage to physical or mental health, or may include social consequences to the drinker or others. It is not a current diagnostic term in ICD-10. Hazardous drinking is usually defined as scoring 8-15 on the Alcohol Use Disorders Identification Test (AUDIT). Definitions of the terminology used by these guidelines are illustrated in Table 1 . Table 3 provides a summary of the recommendations for identifying and managing harmful drinkers in the primary healthcare setting. Only one guideline from the WHO contained recommendations specifically for harmful drinkers (WHO, 2001b SIGN, 2003; DHGC, 2005; DHA, 2009; NICE, 2010; WHO, 2010b WHO, , 2010d CDC, 2014; VA/DOD, 2015) , one guideline by NICE (2011) was for harmful drinking and alcohol dependence, and the seven guidelines were for people with alcohol use disorders, including hazardous, harmful and dependent drinkers (NCETA Consortium, 2004; NIAAA, 2005; SOGC, 2010; Moyer, 2013; WHO, 2014c; RNAO, 2015) . All 17 guidelines recommended screening and brief interventions. All but seven guidelines (WHO, 2001b (WHO, , 2010b NIAAA, 2002 NIAAA, , 2005 NCETA Consortium, 2004; Moyer, 2013; CDC, 2014 ) used a systematic review method to (a) evaluate the available evidence, and (b) formulate recommendations according to expert consensus (Table 3) . Additionally, a search strategy and inclusion criteria were reported by nine guidelines (SIGN, 2003; DHGC, 2005; DHA, 2009; SOGC, 2010; NICE, 2010 NICE, , 2011 WHO, 2014c; RNAO, 2015; VA/ DOD, 2015) .
Recommendations of the guidelines
Screening
Evidence base for screening in primary healthcare settings Five guidelines provided evidence with regard to screening (DHGC, 2005; DHA, 2009; WHO, 2014c; RNAO, 2015; VA/DOD, 2015) . The DHA (2009) guideline from Australia reported from metaanalysis of randomized controlled trials (RCT) that screening in general practice is recommended due to its cost-effectiveness and the high rate of contact with the general public in this setting. The European guideline (DHGC, 2005) also reported evidence that screening rates in the primary care setting are low, so many harmful drinkers are not known to their healthcare provider. Furthermore, based on evidence from several systematic reviews, the VA/DOD (2015) guideline from the US and the RNAO (2015) guideline from Canada found screening followed by brief counseling, to be effective at reducing alcohol consumption in problem drinkers.
Screening different groups
The Canadian guideline by the SOGC (2010) reported from controlled trials that screening pregnant women can reduce primary fetal alcohol spectrum disorder disabilities and related secondary disabilities. Though the evidence quality was graded as low, the WHO still highly recommended universal screening during pregnancy, because it may increase a woman's awareness of the risks associated with alcohol and motivate her to modify behavior (WHO, 2014c) . Routine screening of adolescents for tobacco, alcohol and other drugs was also recommended by the DHA (2009) guideline based on expert opinion, as polydrug use is common among adolescent problem drinkers. But the USPSTF guideline does not recommend screening adolescents due to insufficient evidence (Moyer, 2013) . In addition, DHA (2009) guideline also recommended screening the elderly, as experts believed that alcohol use and related disorders may be mistaken for the effects of ageing.
Questionnaire-based screening
Of the various screening tools recommended by the guidelines, the AUDIT (WHO, 2001a) was the most often recommended tool (Supplementary Table S2 ). Twelve guidelines (WHO, 2001b (WHO, , 2014c NIAAA, 2002 NIAAA, , 2005 NCETA Consortium, 2004; DHA, 2009; NICE, 2010 NICE, , 2011 Moyer, 2013; CDC, 2014; RNAO, 2015 ; VA/ DOD, 2015) recommended using AUDIT for screening based on evidence from systematic reviews, RCTs, and observational studies showing the tool to be effective, with high specificity, sensitivity, validity and reliability. The tool was also found to be more costeffective than biological measures of alcohol, according to the NICE (2010) guidelines.
Eight guidelines mentioned adopting the WHO AUDIT cut-off points of 16-19 for harmful drinking, except for the Australian guideline by the NCETA Consortium (2004), which used 8-15 for men, and 7-15 for women. Furthermore, both the WHO (2001b) and the European guideline (DHGC, 2005) reported from validation studies of the AUDIT that although limited evidence was found on women, it still appears to be equally appropriate for screening both genders. However, these two guidelines also noted that cut-offs of the AUDIT should be modified for different groups and cultures, and four guidelines specifically suggested lowering the threshold for women (NIAAA, 2005; NICE, 2010 NICE, , 2011 VA/DOD, 2015) . In addition, both NICE guidelines found the AUDIT to be appropriate for identifying alcohol misuse in adolescents, however adjusting cutoffs and modifying items to be more relevant to the population should be considered (NICE, 2010 (NICE, , 2011 , as studies have found that lower cut-offs increase sensitivity in this population. As for the elderly (over 65 years of age), low sensitivity but high specificity was reported (WHO, 2001a) . Finally, studies have also found that the AUDIT is appropriate to be used in psychiatric patients (DHA, 2009; VA/DOD, 2015) .
A shorter form of the AUDIT, namely the AUDIT alcohol consumption questions (AUDIT-C), was recommended by seven guidelines (SIGN, 2003; DHGC, 2005; NICE, 2010; Moyer, 2013; RNAO, 2015; WHO, 2014c; VA/DOD, 2015) . Evidence suggests the AUDIT-C is valid and reliable, and is just as effective as the full version of the AUDIT at identifying alcohol misuse (DHGC, 2005; Mean overall AGREE II scores of the three appraisers. Scores were based on a 7-point Likert scale, with 1 being 'Strongly Disagree', and 7 being 'Strongly Agree'. This overall score was calculated based on scores of Domain 3, 4 and 5. 
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Alcohol and Alcoholism, 2017 , Vol. 52, No. 5 NICE, 2010 VA/DOD, 2015) , but should be used with caution as some studies have reported the tool giving false positive results (NICE, 2010 (NICE, , 2011 .
Verbal screening A total of eight guidelines recommended performing screening verbally during clinical interviews (NIAAA, 2002 (NIAAA, , 2005 SIGN, 2003; DHA, 2009; SOGC, 2010; WHO, 2010d; Moyer, 2013; RNAO, 2015) . All five American guidelines (NIAAA, 2002 (NIAAA, , 2005 Moyer, 2013; CDC, 2014; VA/DOD, 2015) recommended asking a single-item screening question about heavy drinking days, as studies showed it was valid, sensitive, specific and reliable for detecting at-risk drinking. The singleitem screening question and quantity-frequency questions about drinking were also recommended by another four guidelines (SIGN, 2003; DHA, 2009; WHO, 2010d) . The RNAO (2015) guidelines recommended asking three universal questions to screen all clients based on review and studies. The NIAAA (2002) guideline reported from cohort studies and reviews that quantity-frequency questions are sensitive at detecting at-risk drinkers, but the DHA (2009) and SIGN (2003) guidelines only based their recommendation on expert opinion. Furthermore, the WHO (2010d) guideline did not provide any evidence for their recommendation.
Biological tests
Three guidelines recommended biological tests as these tests can confirm the presence of alcohol in the body (SIGN, 2003; DHA, 2009; SOGC, 2010) . Two guidelines, however, did not recommend biological tests to be used for routine screening as these tests are not sensitive and accurate at detecting heavy alcohol consumption; thus has limited effectiveness compared to structured questionnaires such as AUDIT (DHGC, 2005; NICE, 2010) . The SIGN (2003) guideline recommended using biological tests if there is reason to believe there is over or under-reporting of alcohol consumption whilst the DHA (2009) guideline recommended direct measures of alcohol (alcohol in breath or blood) as it can be useful for assessing recent alcohol use.
Brief interventions
Evidence base and potential benefits All guidelines recommended brief interventions-treatment approaches that aim to identify and manage drinkers in order to reduce risky alcohol consumption and alcohol-related problems, with the majority of guidelines basing their recommendations on evidence from meta-analyses, systematic reviews or controlled trials. A total of seven guidelines reported that brief interventions in primary healthcare settings are effective interventions for harmful drinkers (WHO, 2001b; SIGN, 2003; DHGC, 2005; DHA, 2009; Moyer, 2013; RNAO, 2015; VA/DOD, 2015) . Brief interventions were found to reduce alcohol intake among non-dependent drinkers in both treatment seeking and non-treatment seeking populations (WHO, 2001b (WHO, , 2010b NIAAA, 2002 NIAAA, , 2005 SIGN, 2003; NCETA Consortium, 2004; DHGC, 2005; DHA, 2009; NICE, 2010; VA/ DOD, 2015) , as well as to reduce alcohol-related problems (NIAAA, 2002; DHGC, 2005; NICE, 2010) . Conservative estimate showed 385 needed to be screened to have one adult patient to benefit (DHGC, 2005) . One guideline reported brief interventions to reduce alcohol consumption by up to 30% (DHA, 2009), and prevent one alcohol-related death within 1 year for every 282 patients receiving brief intervention (DHGC, 2005) .
Potential cost savings Brief interventions were reported by seven guidelines to be costeffective (WHO, 2001b (WHO, , 2010b (WHO, , 2014c NIAAA, 2002 NIAAA, , 2005 SIGN, 2003; DHGC, 2005) , and the long-term effects were maintained for up to 1 year (WHO, 2001b; NIAAA, 2002; DHGC, 2005) . The cost of screening and brief intervention were reported to be between €12 and €185 per 100 patients per year, or US $205 per subject (DHGC, 2005) , with benefit-cost ratios ranging from 3.8 to 5.6: 1 (NIAAA, 2002; DHGC, 2005) . As reported by the DHGC (2005) guideline, brief interventions can save €1960 per DALY prevented in Europe.
In terms of cost savings, the average per subject benefit of conducting brief interventions in primary care was reported to be around US $1151, with cost savings from emergency department and hospital use, as well as from crimes and motor vehicle accidents, as reported by the DHGC (2005) guideline. In addition, healthcare costs were estimated to be reduced by more than four times with every US dollar invested into screening and brief interventions (NIAAA, 2005) .
Target population
As for effectiveness among different groups, brief interventions was found to be effective in both men and women (NIAAA, 2002; DHGC, 2005; NICE, 2010) , and in all age groups (DHGC, 2005; DHA, 2009 ). However, two guidelines could not formulate a recommendation for those under 16 years (NICE, 2010) or adolescents (Moyer, 2013) , as evidence for the effectiveness was not clear. Five guidelines were in favor of brief interventions for pregnant women (NIAAA, 2002; DHGC, 2005; Moyer, 2013; WHO, 2014c; RNAO, 2015) , but another two concluded the evidence was not sufficient to make a recommendation (DHA, 2009; SOGC, 2010) .
Procedures
For the frequency of brief interventions, the DHGC (2005) and WHO (2014c) guidelines found mixed evidence for the effectiveness delivered in one session compared to several sessions. Furthermore, although longer extended brief interventions were also found to be effective by the NICE (2010) guidelines, other guidelines reported inconsistent evidence for its effectiveness, or that it did not appear to be any more effective than very short brief sessions (SIGN, 2003; VA/DOD, 2015) . The NICE (2010) guideline also recommended extended brief interventions for those aged 16-17 years, as most educational institute-based studies using similar forms of intervention have found positive results in those aged 16 years and above. As for the components of brief intervention, limited evidence was available in regards to the most effective component (SIGN, 2003; DHGC, 2005) , but the DHGC (2005), SIGN (2003) and WHO (2014c) guidelines reported the use of motivational interviewing techniques to be effective in brief interventions. On the other hand, the NICE (2010) guideline could not make a recommendation as there was a lack of strong evidence of the benefits of motivational interviewing to make a conclusion, but concluded that motivational interviewing should not be used as a stand-alone treatment, but as part of an intervention.
Barriers and facilitators
Twelve guidelines indicated barriers and facilitators in implementing the recommendations (WHO, 2001b (WHO, , 2010b (WHO, , 2014c NCETA Consortium, 2004; DHGC, 2005; NIAAA, 2005; DHA, 2009; NICE, 2010 NICE, , 2011 SOGC, 2010; Moyer, 2013; RNAO, 2015) . Barriers included lack of available treatment resources, healthcare professionals' lack of training leading to lack of confidence, knowledge and skills, competing priorities, lack of time and financial incentives and discrimination against drinkers (WHO, 2001b (WHO, , 2010b NCETA Consortium, 2004; DHA, 2009; NICE, 2010; Moyer, 2013) . Patients may fear of stigmatization, legal issues such as losing custody of their children, language barrier for immigrants or newcomers, financial barrier or unpleasant effects of reducing drinking (NCETA Consortium, 2004; SOGC, 2010; NICE, 2011) . However, making screening and brief interventions part of routine care, providing enough support and training to healthcare providers, and having healthcare providers show empathy and have a non-judgemental attitude towards harmful drinkers, providing home-visits or telemedicine, facilitated the application of screening and brief interventions (WHO, 2001b; DHGC, 2005; NIAAA, 2005; RNAO, 2015) .
DISCUSSION
Main findings
A total of 17 guidelines were identified to be applicable for managing harmful alcohol use in primary healthcare settings. All guidelines recommended screening and brief interventions, which has been shown to be cost-effective, leading to health and financial benefits. All guidelines recommended screening verbally and/ or using a structured questionnaire, with the majority of the guidelines recommended the latter. The most recommended structured questionnaire was the AUDIT, or the shorter form, AUDIT-C.
Appraisal of the guidelines
Most guidelines used a systematic method for evaluating evidence, but several guidelines had an average overall AGREE scores of <50% of the maximum possible score, in the areas of rigor of development and applicability, due to insufficient or lack of details provided. Future guidelines are encouraged to provide more details on how they obtain evidence from existing studies and reviews, and how the evidence is linked to recommendations. Furthermore, many guidelines did not provide information on future updates of the guideline or on monitoring and assessing the implementation process and results of the guidelines, hence this area resulted in lower AGREE scores. Other reasons that contributed to lower scores were that several guidelines did not have clear information of stakeholders involved in the developmental process, and patients' opinions were also not considered. Despite these shortcomings, it should be noted that the AGREE scores only reflect the information available to us in the guidelines, and that other unpublished supporting details could also exist. Hence, the scores may not reflect the true quality of these guidelines.
Inconsistent terminologies were used across the guidelines, which made comparisons between recommendations challenging. There is a need to unify definitions and criteria in future guidelines, practice or studies, e.g. referring to the DSM-5 and/or ICD-10 criteria. As for limitations on recommendations, unlike all the other guidelines, one guideline (NCETA Consortium, 2004) did not adopt the WHO AUDIT cut-off points of 16-19 for harmful drinking. However, that guideline provided a direct reference to the WHO's AUDIT user manual (WHO, 2001a) ; thus, there is reason to believe that this discrepancy may be a possible error.
Strengths and limitations
This is the first study to systematically review all available guidelines for harmful alcohol use, with the aim to help policy makers in different countries develop their own relevant guidelines, or to provide a reference for future modifications to their existing guidelines, and to help healthcare professionals provide services to harmful drinkers. We have used a comprehensive search strategy to identify relevant guidelines and adopted the well-accepted AGREE II instrument to appraise the quality of the guidelines. All guidelines were developed by governmental, or international organizations, or by a medical speciality society, which strengthens the reliability of the recommendations.
As for limitations, because only guidelines in English were reviewed, eligible guidelines in other languages were possibly missed. Moreover, the guidelines included were mainly from Western countries; hence, the recommendations may not be generalizable to Asian or other populations with possibly different drinking cultures or patterns. However, the guidelines developed by the WHO were intended for international use and have been validated in various countries; hence, they may be relevant to most Asian countries as well (WHO, 2001b (WHO, , 2010b (WHO, , 2010d (WHO, , 2014c .
Implications for practice
Healthcare workers can consider applying the brief interventions under the FRAMES model (DHA, 2009; NICE, 2010; SOGC, 2010; WHO, 2010b) : Feedback-provide feedback on risk or impairment; Responsibility-emphasis it is patient's own responsibility to change; Advice-advise to cut down or abstain; Menu of options-provide options for changes and set alcohol reduction goals jointly with the patient; Empathy-listening reflectively and understandingly without confronting; Self-efficacy-optimize patient's belief in their ability to change. Similar to the FRAMES model, the Feedback, Listen, Advice, Goals, Strategies (FLAGS) structure (DHA, 2009) can be used alternatively. Additionally, for those in their early stage of change (precontemplation (not ready) and contemplation (unsure)), motivational interviewing skills or counseling skills may be used to motivate behavioral changes. Continued follow-up monitoring is also needed. Based on the evidence of the guidelines, a reference flowchart (Fig. 2) was deduced, showing the recommended steps to identify and manage harmful drinking in primary healthcare settings.
There were no consensus across the guidelines on the details of practices of screening and brief interventions, such as who should be screened, who should conduct the screening or brief interventions, the frequency of brief interventions, as well as the length of each intervention. On one hand, in real practice, there is much flexibility, e.g. any healthcare professionals can be eligible to conduct screening and brief interventions given the required training. On the other hand, although brief interventions have been proved to be costeffective, there is still a gap in how to arrange real practice procedures among different target populations in different areas. With the challenges in mind, policy makers should step in and make appropriate arrangement in terms of resource and manpower allocation based on the best evidence and local circumstances. In real practice, they may also need to remove the barriers and enhance the facilitators in applying the recommendations, for example, addressing the misconceptions among some patients who may be reluctant to be screened due to fear of stigmatization and legal issues arising from positive results (Glass et al., 2014; van Boekel et al., 2015) . Evidence suggests stigma and self-stigma can be decreased through therapeutic interventions (e.g. group-based acceptance and commitment therapy), positive stories of patients and education programs targeting on medical students and professionals (e.g. police, counselors) (Livingston et al., 2012; Shim and Rust, 2013; Henderson et al., 2014) . Policy makers may implement these anti-stigma activities and alcohol-related protective legislations in both clinical and non-clinical settings along with the implementation of the evidence-based recommendations. In addition, the CDC (2014) guidelines have provided practical advice on how to apply the recommendations step by step in real practice, which can be referred to.
It is unclear in the identified guidelines of the effectiveness of one session versus several sessions of brief intervention. Some guidelines recommended 1-4 brief intervention sessions but some did not point out the number of needed sessions. A recent systematic review suggested that multi-contacts of brief intervention (10-to 15-minute) were most effective (Jonas et al., 2012a (Jonas et al., , 2012b . Alcohol consumption was decreased by 3.6 (95% Confidence Interval: 2.4-4.8) drinks per week from baseline,~1 in 10 adults were reported no more heavy drinking episodes (risk difference: 0.12 (0.07-0.16)), and~1 in 10 adults were reported drinking less than the recommended limits (risk difference: 0.11 (0.08-0.13)) over 12 months (Jonas et al., 2012a (Jonas et al., , 2012b . However, evidence on longer term effects is still needed among different populations or cultures to strengthen the suggestion on applying multi-contacts of brief intervention.
In terms of target population, because recommendations from most guidelines were for both hazardous and harmful drinkers, it was difficult to review the recommendations for harmful drinkers only. However, the recommendations from the guidelines were similar; hence, primary healthcare professionals should consider adopting the same recommendations for both types of drinkers.
Contrasting evidence on the effectiveness of brief interventions for younger populations, pregnant women and women planning to become pregnant were found due to insufficient evidence, small sample size and lack of recent studies. Hence, the recommendations in favor of brief interventions for these populations should be applied with caution.
Implications for research
Although all guidelines have found promising evidence for screening and brief interventions for harmful alcohol use in primary healthcare, some areas are still uncertain and thus need further considerations or research.
First, there is a need to further investigate the effectiveness of screening and brief interventions in specific populations, including young people, pregnant women, drinkers with co-morbidities, Asian populations or other specific cultural groups, as most studies conducted were on adults or students over 16 years of age, as well as in Western populations. With the fact that different races have various alcohol sensitivities (Chan, 1986) , it is worthy to further explore the specific criteria or cut-off points of screening tests such as AUDIT, to identify harmful drinkers.
Second, there is a need to study the brief interventions in different populations and areas, e.g. the long-term effects over one or more years, and the interval of brief interventions. A recent systematic review of brief interventions in primary care populations in middle income countries was only able to find nine RCTs from four countries (India, Brazil, Thailand and South Africa) out of more than 100 middle income countries, with only one study followed up to 24 months (Joseph and Basu, 2017) . More studies are certainly needed.
Further assessment if required
Screening
Consumption questions and/or structured questionnaires (AUDIT; AUDIT-C; TWEAK/T-ACE for pregnant women) 
Encouragement and Reinforcement
Referral Extended Brief Intervention
Deliver motivational interviewing by appropriately trained staff Third, outcome evaluation after adopting the recommendations in primary healthcare settings should be established, e.g. alcohol consumption reduction rate, abstinence and relapse rate and incidence of alcohol-related physical/mental/social problems, otherwise it will be difficult to evaluate the achievements or the social influence of the services. Ultimately, more health economical assessments such as the cost to sustain the services and the benefits in the long run are still needed.
CONCLUSIONS
Recommendations on identifying and managing harmful alcohol use in primary healthcare settings were generally consistent across the 17 guidelines. Screening and brief interventions were recommended by majority of the guidelines. Given the effectiveness and costeffectiveness of screening and brief interventions, policy makers and primary healthcare providers are highly encouraged to integrate these practices into primary healthcare settings taking the drinking status, culture and resources into account. Further exploration is needed in the planning, resource allocation, implementation and evaluation of screening and brief interventions in primary healthcare settings.
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